A) The ease of obtaining stem cells from adults. B) The use of embryonic stem cells. C) The lack of potential applications. D) The uncontroversial ethical implications.
A) Funding from private corporations only. B) Speed of research progress above all else. C) Ethical guidelines and regulations. D) Ignoring public opinions and concerns.
A) To address regulatory disparities and ensure ethical standards. B) To eliminate competition among research institutions. C) To avoid sharing scientific breakthroughs. D) To hinder progress in the field.
A) Creating financial barriers to stem cell research. B) Excluding patient advocates from the research process. C) Promoting unregulated stem cell experimentation. D) Developing international policy guidance on stem cell research.
A) Replace traditional medicine for all illnesses. B) Repair, replace, and regenerate damaged cells or tissues. C) Create artificial intelligence using stem cells. D) Speed up the aging process in patients.
A) To prioritize scientific progress over societal implications. B) To address diverse views on ethics, religious beliefs, and values that impact policy decisions. C) To only focus on economic factors. D) To ignore public opinions and concerns.
A) Opposing all forms of medical research involving stem cells. B) Providing expertise on ethical implications and considerations. C) Advocating for unrestricted research with no ethical oversight. D) Serving as decision-makers for all stem cell research projects.
A) There is no difference between the two types of stem cells. B) Pluripotent cells are more versatile than totipotent cells. C) Pluripotent cells can only divide a limited number of times. D) Totipotent cells can develop into any type of cell, including embryonic tissues, while pluripotent cells can develop into almost any type of cell. |